Home > Boards > US OTC > Biotechs > Inhibitor Therapeutics Inc. (INTI)

News Out!! - More positive updates from Clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
CaptHowdy Member Profile
 
Followed By 38
Posts 2,064
Boards Moderated 1
Alias Born 11/11/14
160x600 placeholder
CaptHowdy   Thursday, 10/20/16 08:23:17 AM
Re: None
Post # of 388 
News Out!! - More positive updates from Clinical trials for Basal Cell Carcinoma

HedgePath Pharmaceuticals Announces Further Positive Interim Data in its Phase II(b) Cancer Trial


18 subjects with Basal Cell Carcinoma Nevus Syndrome who had 231 surgically eligible tumors complete 16 weeks of dosing with SUBA™-Itraconazole

Second interim analysis shows a statistically significant mean target tumor burden reduction (P<0.0001) and 11 of 18 trial subjects to date achieving a 30% or greater reduction in target tumor burden

Full Article: http://www.prnewswire.com/news-releases/hedgepath-pharmaceuticals-announces-further-positive-interim-data-in-its-phase-iib-cancer-trial-300348148.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist